
    
      This study is partially Double-Blinded in that the participants' parents/guardians,
      investigator/study site personnel, and Sponsor's representatives will be blinded to the lot
      of V419 the participant is randomized to receive, but not to the participant's treatment
      group (V419 or control).
    
  